Entheon Biomedical Corp Stock Probability of Future OTC Stock Price Finishing Over 0.086
| ENTBF Stock | USD 0.12 0.04 60.00% |
Entheon |
Entheon Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Entheon Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Entheon Biomedical Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Entheon Biomedical is way too risky over 90 days horizon | |
| Entheon Biomedical has some characteristics of a very speculative penny stock | |
| Entheon Biomedical appears to be risky and price may revert if volatility continues | |
| Entheon Biomedical Corp has accumulated 300 K in total debt with debt to equity ratio (D/E) of 0.05, which may suggest the company is not taking enough advantage from borrowing. Entheon Biomedical Corp has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Entheon Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Entheon Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Entheon Biomedical Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Entheon to invest in growth at high rates of return. When we think about Entheon Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 21.67 K. Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 9.13 K. | |
| Entheon Biomedical Corp has accumulated about 467.58 K in cash with (5.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Entheon Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Entheon OTC Stock often depends not only on the future outlook of the current and potential Entheon Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Entheon Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 59.1 M |
Entheon Biomedical Technical Analysis
Entheon Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Entheon OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Entheon Biomedical Corp. In general, you should focus on analyzing Entheon OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Entheon Biomedical Predictive Forecast Models
Entheon Biomedical's time-series forecasting models is one of many Entheon Biomedical's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Entheon Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Entheon Biomedical Corp
Checking the ongoing alerts about Entheon Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Entheon Biomedical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Entheon Biomedical is way too risky over 90 days horizon | |
| Entheon Biomedical has some characteristics of a very speculative penny stock | |
| Entheon Biomedical appears to be risky and price may revert if volatility continues | |
| Entheon Biomedical Corp has accumulated 300 K in total debt with debt to equity ratio (D/E) of 0.05, which may suggest the company is not taking enough advantage from borrowing. Entheon Biomedical Corp has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Entheon Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Entheon Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Entheon Biomedical Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Entheon to invest in growth at high rates of return. When we think about Entheon Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 21.67 K. Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 9.13 K. | |
| Entheon Biomedical Corp has accumulated about 467.58 K in cash with (5.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Other Information on Investing in Entheon OTC Stock
Entheon Biomedical financial ratios help investors to determine whether Entheon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entheon with respect to the benefits of owning Entheon Biomedical security.